ArticleFrontiers in surgery2025
Impact of intraoperative packed red blood cell transfusion volume on prognosis in CRS: a propensity-matched study.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an effective treatment for peritoneal metastasis but is associated with significant blood loss requiring intraoperative red blood cell (RBC) transfusion. Evidence suggests transfusions may impair immunity and worsen oncologic outcomes, yet the prognostic impact of intraoperative packed RBC transfusion (iPRBT), especially transfusion volume, in CRS/HIPEC remains unclear. Methods: We conducted a single-center, retrospective study of 128 patients with advanced peritoneal metastasis who underwent CRS with intraoperative RBC transfusion between January 2018 and December 2024. Patients were stratified into low transfusion (≤4 units) and high transfusion (>4 units) groups. Propensity score matching (PSM) was applied to control for key covariates including CC score, operative time, blood loss, preoperative peritoneal cancer index (PCI), platelet count, age, and gender. Postoperative complications (Clavien-Dindo grade ≥ II) and overall survival (OS) were analyzed. Results: A total of 128 patients were included, among whom high intraoperative transfusion volume was significantly associated with higher CC score, greater blood loss, longer operative time, elevated preoperative PCI, and lower preoperative platelet counts. After propensity score matching, 48 patients were analyzed. The overall complication rate was 39.6%, with no significant difference between groups ( Conclusions: Higher iPRBT may ease postoperative anemia but is associated with poorer long-term survival, without a clear link to postoperative complications. These findings support a more restrictive transfusion strategy in CRS/HIPEC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.